Fms-Albany Regional Kidney Center is a medicare approved dialysis facility center in Albany, New York and it has 34 dialysis stations. It is located in Albany county at 2 Clara Barton Drive, Albany, NY, 12208. You can reach out to the office of Fms-Albany Regional Kidney Center at (518) 434-6565. This dialysis clinic is managed and/or owned by Fresenius Medical Care. Fms-Albany Regional Kidney Center has the following ownership type - Profit. It was first certified by medicare in May, 1997. The medicare id for this facility is 332569 and it accepts patients under medicare ESRD program.
| Name | Fms-Albany Regional Kidney Center |
|---|---|
| Location | 2 Clara Barton Drive, Albany, New York |
| No. of Dialysis Stations | 34 |
| Medicare ID | 332569 |
| Managed By | Fresenius Medical Care |
| Ownership Type | Profit |
| Late Shifts | Yes |
| 2 Clara Barton Drive, Albany, New York, 12208 | |
| (518) 434-6565 | |
News Archive
IBM is working with researchers at the University of Medicine and Dentistry of New Jersey (UMDNJ) - Robert Wood Johnson Medical School and The Cancer Institute of New Jersey to unleash supercomputer technology in the battle against cancer.
California Stem Cell, Inc. (CSC) and ALS Therapy Development Institute (ALS TDI) are pleased to announce an extension and expansion of their collaboration aimed at advancing a potential stem cell therapy for ALS (amyotrophic lateral sclerosis). This effort will build on work that has already been completed as part of this on-going partnership to understand how stem cells, and their derivatives, may be applied to treatment of this fatal neurodegenerative disease.
AstraZeneca has announced that the U.S. Food and Drug Administration has approved revised labeling for its anti-inflammatory corticosteroid nasal spray RHINOCORT AQUA® (budesonide).
While the U.S. has begun to vaccinate millions of Americans each day, COVID-19 vaccine supplies around the world remain scarce.
MIT researchers have developed a way to incorporate electronic sensors into stretchy fabrics, allowing them to create shirts or other garments that could be used to monitor vital signs such as temperature, respiration, and heart rate.
› Verified 6 days ago
| NPI Number | 1508960378 |
| Organization Name | Fms-albany Regional Kidney Center |
| Doing Business As | New York Dialysis Services, Inc. |
| Address | 2 Clara Barton Drive Albany, New York, 12208 |
| Phone Number | (518) 434-6565 |
News Archive
IBM is working with researchers at the University of Medicine and Dentistry of New Jersey (UMDNJ) - Robert Wood Johnson Medical School and The Cancer Institute of New Jersey to unleash supercomputer technology in the battle against cancer.
California Stem Cell, Inc. (CSC) and ALS Therapy Development Institute (ALS TDI) are pleased to announce an extension and expansion of their collaboration aimed at advancing a potential stem cell therapy for ALS (amyotrophic lateral sclerosis). This effort will build on work that has already been completed as part of this on-going partnership to understand how stem cells, and their derivatives, may be applied to treatment of this fatal neurodegenerative disease.
AstraZeneca has announced that the U.S. Food and Drug Administration has approved revised labeling for its anti-inflammatory corticosteroid nasal spray RHINOCORT AQUA® (budesonide).
While the U.S. has begun to vaccinate millions of Americans each day, COVID-19 vaccine supplies around the world remain scarce.
MIT researchers have developed a way to incorporate electronic sensors into stretchy fabrics, allowing them to create shirts or other garments that could be used to monitor vital signs such as temperature, respiration, and heart rate.
› Verified 6 days ago
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Patients who reported that nephrologists always communicated and cared for them. | 37% | 67% |
| Patients who reported that nephrologists usually communicated and cared for them. | 12% | 15% |
| Patients who reported that nephrologists sometimes or never communicated and cared for them. | 51% | 18% |
| Patients who gave their nephrologists a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible). | 27% | 60% |
| Patients who gave their nephrologists a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible). | 33% | 26% |
| Patients who gave their nephrologists a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible). | 40% | 14% |
News Archive
IBM is working with researchers at the University of Medicine and Dentistry of New Jersey (UMDNJ) - Robert Wood Johnson Medical School and The Cancer Institute of New Jersey to unleash supercomputer technology in the battle against cancer.
California Stem Cell, Inc. (CSC) and ALS Therapy Development Institute (ALS TDI) are pleased to announce an extension and expansion of their collaboration aimed at advancing a potential stem cell therapy for ALS (amyotrophic lateral sclerosis). This effort will build on work that has already been completed as part of this on-going partnership to understand how stem cells, and their derivatives, may be applied to treatment of this fatal neurodegenerative disease.
AstraZeneca has announced that the U.S. Food and Drug Administration has approved revised labeling for its anti-inflammatory corticosteroid nasal spray RHINOCORT AQUA® (budesonide).
While the U.S. has begun to vaccinate millions of Americans each day, COVID-19 vaccine supplies around the world remain scarce.
MIT researchers have developed a way to incorporate electronic sensors into stretchy fabrics, allowing them to create shirts or other garments that could be used to monitor vital signs such as temperature, respiration, and heart rate.
› Verified 6 days ago
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Patients who reported that dialysis center staff always communicated well, kept patients comfortable and pain-free as possible. | 58% | 62% |
| Patients who reported that dialysis center staff usually communicated, kept patients comfortable and pain-free as possible. | 23% | 20% |
| Patients who reported that dialysis center staff sometimes or never communicated, kept patients comfortable and pain-free. | 19% | 18% |
| Patients who gave their dialysis facility staff a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible). | 49% | 62% |
| Patients who gave their dialysis facility staff a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible). | 40% | 26% |
| Patients who gave their dialysis facility staff a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible). | 11% | 12% |
News Archive
IBM is working with researchers at the University of Medicine and Dentistry of New Jersey (UMDNJ) - Robert Wood Johnson Medical School and The Cancer Institute of New Jersey to unleash supercomputer technology in the battle against cancer.
California Stem Cell, Inc. (CSC) and ALS Therapy Development Institute (ALS TDI) are pleased to announce an extension and expansion of their collaboration aimed at advancing a potential stem cell therapy for ALS (amyotrophic lateral sclerosis). This effort will build on work that has already been completed as part of this on-going partnership to understand how stem cells, and their derivatives, may be applied to treatment of this fatal neurodegenerative disease.
AstraZeneca has announced that the U.S. Food and Drug Administration has approved revised labeling for its anti-inflammatory corticosteroid nasal spray RHINOCORT AQUA® (budesonide).
While the U.S. has begun to vaccinate millions of Americans each day, COVID-19 vaccine supplies around the world remain scarce.
MIT researchers have developed a way to incorporate electronic sensors into stretchy fabrics, allowing them to create shirts or other garments that could be used to monitor vital signs such as temperature, respiration, and heart rate.
› Verified 6 days ago
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Patients who reported that 'YES', their nephrologists and dialysis center staff provided them the information they needed to take care of them. | 79% | 80% |
| Patients who reported that 'NO', their nephrologists and dialysis center staff does not provided them the information they needed to take care of them. | 21% | 20% |
| Patients who gave their dialysis center a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible). | 48% | 68% |
| Patients who gave their dialysis center a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible). | 30% | 20% |
| Patients who gave their dialysis center a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible). | 22% | 12% |
News Archive
IBM is working with researchers at the University of Medicine and Dentistry of New Jersey (UMDNJ) - Robert Wood Johnson Medical School and The Cancer Institute of New Jersey to unleash supercomputer technology in the battle against cancer.
California Stem Cell, Inc. (CSC) and ALS Therapy Development Institute (ALS TDI) are pleased to announce an extension and expansion of their collaboration aimed at advancing a potential stem cell therapy for ALS (amyotrophic lateral sclerosis). This effort will build on work that has already been completed as part of this on-going partnership to understand how stem cells, and their derivatives, may be applied to treatment of this fatal neurodegenerative disease.
AstraZeneca has announced that the U.S. Food and Drug Administration has approved revised labeling for its anti-inflammatory corticosteroid nasal spray RHINOCORT AQUA® (budesonide).
While the U.S. has begun to vaccinate millions of Americans each day, COVID-19 vaccine supplies around the world remain scarce.
MIT researchers have developed a way to incorporate electronic sensors into stretchy fabrics, allowing them to create shirts or other garments that could be used to monitor vital signs such as temperature, respiration, and heart rate.
› Verified 6 days ago
| Dialysis patients with Hemoglobin data | 113 |
| Medicare patients who had average hemoglobin (hgb) less than 10 g/dL | 12 |
News Archive
IBM is working with researchers at the University of Medicine and Dentistry of New Jersey (UMDNJ) - Robert Wood Johnson Medical School and The Cancer Institute of New Jersey to unleash supercomputer technology in the battle against cancer.
California Stem Cell, Inc. (CSC) and ALS Therapy Development Institute (ALS TDI) are pleased to announce an extension and expansion of their collaboration aimed at advancing a potential stem cell therapy for ALS (amyotrophic lateral sclerosis). This effort will build on work that has already been completed as part of this on-going partnership to understand how stem cells, and their derivatives, may be applied to treatment of this fatal neurodegenerative disease.
AstraZeneca has announced that the U.S. Food and Drug Administration has approved revised labeling for its anti-inflammatory corticosteroid nasal spray RHINOCORT AQUA® (budesonide).
While the U.S. has begun to vaccinate millions of Americans each day, COVID-19 vaccine supplies around the world remain scarce.
MIT researchers have developed a way to incorporate electronic sensors into stretchy fabrics, allowing them to create shirts or other garments that could be used to monitor vital signs such as temperature, respiration, and heart rate.
› Verified 6 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
| Adult patients getting regular hemodialysis at the center | 186 |
| Adult patient months included in Kt/V greater than or equal to 1.2 | 1774 |
| Percentage of adult patients getting regular hemodialysis at the center | 98 |
News Archive
IBM is working with researchers at the University of Medicine and Dentistry of New Jersey (UMDNJ) - Robert Wood Johnson Medical School and The Cancer Institute of New Jersey to unleash supercomputer technology in the battle against cancer.
California Stem Cell, Inc. (CSC) and ALS Therapy Development Institute (ALS TDI) are pleased to announce an extension and expansion of their collaboration aimed at advancing a potential stem cell therapy for ALS (amyotrophic lateral sclerosis). This effort will build on work that has already been completed as part of this on-going partnership to understand how stem cells, and their derivatives, may be applied to treatment of this fatal neurodegenerative disease.
AstraZeneca has announced that the U.S. Food and Drug Administration has approved revised labeling for its anti-inflammatory corticosteroid nasal spray RHINOCORT AQUA® (budesonide).
While the U.S. has begun to vaccinate millions of Americans each day, COVID-19 vaccine supplies around the world remain scarce.
MIT researchers have developed a way to incorporate electronic sensors into stretchy fabrics, allowing them to create shirts or other garments that could be used to monitor vital signs such as temperature, respiration, and heart rate.
› Verified 6 days ago
| Adult patients getting regular peritoneal dialysis at the center | 40 |
| Adult patient months included in Kt/V greater than or equal to 1.7 | 342 |
| Percentage of adult patients getting regular peritoneal dialysis at the center | 99 |
News Archive
IBM is working with researchers at the University of Medicine and Dentistry of New Jersey (UMDNJ) - Robert Wood Johnson Medical School and The Cancer Institute of New Jersey to unleash supercomputer technology in the battle against cancer.
California Stem Cell, Inc. (CSC) and ALS Therapy Development Institute (ALS TDI) are pleased to announce an extension and expansion of their collaboration aimed at advancing a potential stem cell therapy for ALS (amyotrophic lateral sclerosis). This effort will build on work that has already been completed as part of this on-going partnership to understand how stem cells, and their derivatives, may be applied to treatment of this fatal neurodegenerative disease.
AstraZeneca has announced that the U.S. Food and Drug Administration has approved revised labeling for its anti-inflammatory corticosteroid nasal spray RHINOCORT AQUA® (budesonide).
While the U.S. has begun to vaccinate millions of Americans each day, COVID-19 vaccine supplies around the world remain scarce.
MIT researchers have developed a way to incorporate electronic sensors into stretchy fabrics, allowing them to create shirts or other garments that could be used to monitor vital signs such as temperature, respiration, and heart rate.
› Verified 6 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Fms-Albany Regional Kidney Center with elevated calcium levels.
| Patients with hypercalcemia | 243 |
| Hypercalcemia patient months | 2283 |
| Patients with Serumphosphor | 253 |
| Patients with Serumphosphor less than 3.5 mg/dL | 9 |
| Patients with Serumphosphor from 3.5 to 4.5 mg/dL | 27 |
| Patients with Serumphosphor from 4.6 to 5.5 mg/dL | 30 |
| Patients with Serumphosphor from 5.6 to 7 mg/dL | 25 |
| Patients with Serumphosphor greater than 7 mg/dL | 9 |
News Archive
IBM is working with researchers at the University of Medicine and Dentistry of New Jersey (UMDNJ) - Robert Wood Johnson Medical School and The Cancer Institute of New Jersey to unleash supercomputer technology in the battle against cancer.
California Stem Cell, Inc. (CSC) and ALS Therapy Development Institute (ALS TDI) are pleased to announce an extension and expansion of their collaboration aimed at advancing a potential stem cell therapy for ALS (amyotrophic lateral sclerosis). This effort will build on work that has already been completed as part of this on-going partnership to understand how stem cells, and their derivatives, may be applied to treatment of this fatal neurodegenerative disease.
AstraZeneca has announced that the U.S. Food and Drug Administration has approved revised labeling for its anti-inflammatory corticosteroid nasal spray RHINOCORT AQUA® (budesonide).
While the U.S. has begun to vaccinate millions of Americans each day, COVID-19 vaccine supplies around the world remain scarce.
MIT researchers have developed a way to incorporate electronic sensors into stretchy fabrics, allowing them to create shirts or other garments that could be used to monitor vital signs such as temperature, respiration, and heart rate.
› Verified 6 days ago
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
| Patients included in arterial venous fistula and catheter summaries | 165 |
| Patient months included in arterial venous fistula and catheter summaries | 1465 |
| Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | 50 |
| Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer | 21 |
News Archive
IBM is working with researchers at the University of Medicine and Dentistry of New Jersey (UMDNJ) - Robert Wood Johnson Medical School and The Cancer Institute of New Jersey to unleash supercomputer technology in the battle against cancer.
California Stem Cell, Inc. (CSC) and ALS Therapy Development Institute (ALS TDI) are pleased to announce an extension and expansion of their collaboration aimed at advancing a potential stem cell therapy for ALS (amyotrophic lateral sclerosis). This effort will build on work that has already been completed as part of this on-going partnership to understand how stem cells, and their derivatives, may be applied to treatment of this fatal neurodegenerative disease.
AstraZeneca has announced that the U.S. Food and Drug Administration has approved revised labeling for its anti-inflammatory corticosteroid nasal spray RHINOCORT AQUA® (budesonide).
While the U.S. has begun to vaccinate millions of Americans each day, COVID-19 vaccine supplies around the world remain scarce.
MIT researchers have developed a way to incorporate electronic sensors into stretchy fabrics, allowing them to create shirts or other garments that could be used to monitor vital signs such as temperature, respiration, and heart rate.
› Verified 6 days ago
The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
| Standard Hospitalization Summary Ratio(SHR) Year | January, 2016 - December, 2016 |
| Patients in facility's Hospitalization Summary | 209 |
| Hospitalization Rate in facility | 216.1 (As Expected) |
| Hospitalization Rate: Upper Confidence Limit | 298 |
| Hospitalization Rate: Lower Confidence Limit | 164.5 |
News Archive
IBM is working with researchers at the University of Medicine and Dentistry of New Jersey (UMDNJ) - Robert Wood Johnson Medical School and The Cancer Institute of New Jersey to unleash supercomputer technology in the battle against cancer.
California Stem Cell, Inc. (CSC) and ALS Therapy Development Institute (ALS TDI) are pleased to announce an extension and expansion of their collaboration aimed at advancing a potential stem cell therapy for ALS (amyotrophic lateral sclerosis). This effort will build on work that has already been completed as part of this on-going partnership to understand how stem cells, and their derivatives, may be applied to treatment of this fatal neurodegenerative disease.
AstraZeneca has announced that the U.S. Food and Drug Administration has approved revised labeling for its anti-inflammatory corticosteroid nasal spray RHINOCORT AQUA® (budesonide).
While the U.S. has begun to vaccinate millions of Americans each day, COVID-19 vaccine supplies around the world remain scarce.
MIT researchers have developed a way to incorporate electronic sensors into stretchy fabrics, allowing them to create shirts or other garments that could be used to monitor vital signs such as temperature, respiration, and heart rate.
› Verified 6 days ago
The rate of readmission show you whether patients who were being treated regularly at Fms-Albany Regional Kidney Center were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.
| Standard Readmission Summary Ratio(SRR) Year | January, 2016 - December, 2016 |
| Readmission Rate in facility | 25.3 (As Expected) |
| Readmission Rate: Upper Confidence Limit | 30.2 |
| Readmission Rate: Lower Confidence Limit | 20.7 |
News Archive
IBM is working with researchers at the University of Medicine and Dentistry of New Jersey (UMDNJ) - Robert Wood Johnson Medical School and The Cancer Institute of New Jersey to unleash supercomputer technology in the battle against cancer.
California Stem Cell, Inc. (CSC) and ALS Therapy Development Institute (ALS TDI) are pleased to announce an extension and expansion of their collaboration aimed at advancing a potential stem cell therapy for ALS (amyotrophic lateral sclerosis). This effort will build on work that has already been completed as part of this on-going partnership to understand how stem cells, and their derivatives, may be applied to treatment of this fatal neurodegenerative disease.
AstraZeneca has announced that the U.S. Food and Drug Administration has approved revised labeling for its anti-inflammatory corticosteroid nasal spray RHINOCORT AQUA® (budesonide).
While the U.S. has begun to vaccinate millions of Americans each day, COVID-19 vaccine supplies around the world remain scarce.
MIT researchers have developed a way to incorporate electronic sensors into stretchy fabrics, allowing them to create shirts or other garments that could be used to monitor vital signs such as temperature, respiration, and heart rate.
› Verified 6 days ago
Hemodialysis treatment requires direct access to the bloodstream, which can be an opportunity for germs to enter the body and cause infection. This information shows how often patients at Fms-Albany Regional Kidney Center get infections in their blood each year compared to the number of infections expected for the center based on the national average.
| Standard Infection Summary Ratio(SIR) Year | January, 2016 - December, 2016 |
| Infection Rate in facility | .61 (As Expected) |
| SIR: Upper Confidence Limit | 1.07 |
| SIR: Lower Confidence Limit | .32 |
News Archive
IBM is working with researchers at the University of Medicine and Dentistry of New Jersey (UMDNJ) - Robert Wood Johnson Medical School and The Cancer Institute of New Jersey to unleash supercomputer technology in the battle against cancer.
California Stem Cell, Inc. (CSC) and ALS Therapy Development Institute (ALS TDI) are pleased to announce an extension and expansion of their collaboration aimed at advancing a potential stem cell therapy for ALS (amyotrophic lateral sclerosis). This effort will build on work that has already been completed as part of this on-going partnership to understand how stem cells, and their derivatives, may be applied to treatment of this fatal neurodegenerative disease.
AstraZeneca has announced that the U.S. Food and Drug Administration has approved revised labeling for its anti-inflammatory corticosteroid nasal spray RHINOCORT AQUA® (budesonide).
While the U.S. has begun to vaccinate millions of Americans each day, COVID-19 vaccine supplies around the world remain scarce.
MIT researchers have developed a way to incorporate electronic sensors into stretchy fabrics, allowing them to create shirts or other garments that could be used to monitor vital signs such as temperature, respiration, and heart rate.
› Verified 6 days ago
Patients with anemia require blood transfusions if their anemia is not managed well by their dialysis center. This information shows whether Fms-Albany Regional Kidney Center's rate of transfusions is better than expected, as expected, or worse than expected, compared to other centers that treat similar patients.
| Standard Transfusion Summary Ratio (STrR) Year | January, 2016 - December, 2016 |
| Patients in facility's Transfusion Summary | 174 |
| Transfusion Rate in facility | 46.9 (As Expected) |
| Transfusion Rate: Upper Confidence Limit | 78.1 |
| Transfusion Rate: Lower Confidence Limit | 30 |
News Archive
IBM is working with researchers at the University of Medicine and Dentistry of New Jersey (UMDNJ) - Robert Wood Johnson Medical School and The Cancer Institute of New Jersey to unleash supercomputer technology in the battle against cancer.
California Stem Cell, Inc. (CSC) and ALS Therapy Development Institute (ALS TDI) are pleased to announce an extension and expansion of their collaboration aimed at advancing a potential stem cell therapy for ALS (amyotrophic lateral sclerosis). This effort will build on work that has already been completed as part of this on-going partnership to understand how stem cells, and their derivatives, may be applied to treatment of this fatal neurodegenerative disease.
AstraZeneca has announced that the U.S. Food and Drug Administration has approved revised labeling for its anti-inflammatory corticosteroid nasal spray RHINOCORT AQUA® (budesonide).
While the U.S. has begun to vaccinate millions of Americans each day, COVID-19 vaccine supplies around the world remain scarce.
MIT researchers have developed a way to incorporate electronic sensors into stretchy fabrics, allowing them to create shirts or other garments that could be used to monitor vital signs such as temperature, respiration, and heart rate.
› Verified 6 days ago
The rate of mortality show you whether patients who were being treated regularly at Fms-Albany Regional Kidney Center lived longer than expected (better than expected), don’t live as long as expected (worse than expected), or lived as long as expected (as expected), compared to similar patients treated at other facilities.
| Standard Survival Summary Ratio(SIR) Year | January, 2013 - December, 2016 |
| Patients in facility's Survival Summary | 1044 |
| Mortality Rate in facility | 14.1 (Better than Expected) |
| Mortality Rate: Upper Confidence Limit | 17.1 |
| Mortality Rate: Lower Confidence Limit | 11.5 |
News Archive
IBM is working with researchers at the University of Medicine and Dentistry of New Jersey (UMDNJ) - Robert Wood Johnson Medical School and The Cancer Institute of New Jersey to unleash supercomputer technology in the battle against cancer.
California Stem Cell, Inc. (CSC) and ALS Therapy Development Institute (ALS TDI) are pleased to announce an extension and expansion of their collaboration aimed at advancing a potential stem cell therapy for ALS (amyotrophic lateral sclerosis). This effort will build on work that has already been completed as part of this on-going partnership to understand how stem cells, and their derivatives, may be applied to treatment of this fatal neurodegenerative disease.
AstraZeneca has announced that the U.S. Food and Drug Administration has approved revised labeling for its anti-inflammatory corticosteroid nasal spray RHINOCORT AQUA® (budesonide).
While the U.S. has begun to vaccinate millions of Americans each day, COVID-19 vaccine supplies around the world remain scarce.
MIT researchers have developed a way to incorporate electronic sensors into stretchy fabrics, allowing them to create shirts or other garments that could be used to monitor vital signs such as temperature, respiration, and heart rate.
› Verified 6 days ago
Fms-Albany Dialysis Center Location: 64 Albany Shaker Road, Albany, New York, 12204 Phone: (518) 427-0473 |
Fms-Albany Regional Kidney Center Location: 2 Clara Barton Drive, Albany, New York, 12208 Phone: (518) 434-6565 |
Dialysis Clinic, Inc. Location: 176 Washington Ave Extension, Albany, New York, 12203 Phone: (518) 456-2429 |
FMS Westmere Dialysis Center Location: 178 Washington Ave Extension, Albany, New York, 12203 Phone: (518) 407-0505 |
News Archive
IBM is working with researchers at the University of Medicine and Dentistry of New Jersey (UMDNJ) - Robert Wood Johnson Medical School and The Cancer Institute of New Jersey to unleash supercomputer technology in the battle against cancer.
California Stem Cell, Inc. (CSC) and ALS Therapy Development Institute (ALS TDI) are pleased to announce an extension and expansion of their collaboration aimed at advancing a potential stem cell therapy for ALS (amyotrophic lateral sclerosis). This effort will build on work that has already been completed as part of this on-going partnership to understand how stem cells, and their derivatives, may be applied to treatment of this fatal neurodegenerative disease.
AstraZeneca has announced that the U.S. Food and Drug Administration has approved revised labeling for its anti-inflammatory corticosteroid nasal spray RHINOCORT AQUA® (budesonide).
While the U.S. has begun to vaccinate millions of Americans each day, COVID-19 vaccine supplies around the world remain scarce.
MIT researchers have developed a way to incorporate electronic sensors into stretchy fabrics, allowing them to create shirts or other garments that could be used to monitor vital signs such as temperature, respiration, and heart rate.
› Verified 6 days ago